Ancora Advisors, LLC Fennec Pharmaceuticals Inc. Transaction History

Ancora Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$7.63 - $10.22 $38,150 - $51,100	5,000 Added 69.01%	12,245 $118,000
Q3 2022 Nov 14, 2022	BUY	$5.71 - $8.54 $7,108 - $10,632	1,245 Added 20.75%	7,245 $59,000
Q1 2022 May 16, 2022	BUY	$4.29 - $6.08 $25,740 - $36,480	6,000 New	6,000 $34,000
Q1 2022 May 13, 2022	SELL	$4.29 - $6.08 $25,740 - $36,480	-6,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.51 - $9.62 $39,060 - $57,719	6,000 New	6,000 $57,000

14.8M

10K

83.8K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $151M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.